| Life Science Stars |
REGULATORYMark A Heller, Washington, DC
INTELLECTUAL PROPERTYKevin J Culligan, New York
Marta E Delsignore, New York
Duncan A Greenhalgh, Boston
Marta E Gross, New York
David M Hashmall, New York
David E Kleinfeld, San Diego
Francis C Lynch, Boston
Edmund “Ted” Pitcher, Boston
Frederick H Rein, New York
Daryl L Wiesen, Boston
FINANCE & TRANSACTIONALMitchell S Bloom, Boston
Kingsley L Taft, Boston
Lawrence S Wittenberg, Boston
NON-IP LITIGATION AND ENFORCEMENTJoanne M Gray, New York |
The life sciences team at Boston-based Goodwin Procter can handle a wide array of industry matters, including FDA issues, corporate and transactional work, and most notably, intellectual property matters. The firm represents roughly 400 life sciences clients, both public and private, ranging from established Fortune 100 companies to industry start-ups.
Mark Heller, chair of the firm's FDA Group, is respected by competitors who call him "an enormously talented attorney and nice person." Heller has nearly 10 years of experience in the chief counsel's office of the FDA and focuses on FTC issues in addition to counseling clients on FDA issues.
A trio of respected attorneys, Mitchell Bloom, Kingsley Taft and Lawrence Wittenberg, handle client matters on the finance and transactional side. Bloom often acts as a trusted advisor and as an outside general counsel for start-up companies in the sector. Taft has a Ph.D. in Chemistry from MIT and like Bloom, also regularly serves as an outside counsel to life sciences companies. All three are superb attorneys who are well-versed in handling mergers, joint-ventures, and licensing or collaborative transactions.
One area where Goodwin Procter distances itself from the market is within the intellectual property space. Over 175 IP attorneys at the firm are focused on protecting their client's assets through what the firm likes to call "end-to-end" patent services–prosecution all the way to litigation. And in order to offer a comprehensive package, Goodwin is staffed with an extensive group of patent attorneys, a handful of former patent office examiners, and a number of scientific advisors.
Part of what the firm prides itself on is preparing clients on patent application preparation, especially with an eye towards anticipating future litigation. One of the industry's mainstays is partner Edmund "Ted" Pitcher, who utilizes over three decades of experience. Pitcher possesses a deep understanding of what an IP portfolio must contain in order for it to succeed and become a valuable asset for the client.
Edmund is backed by a number of stars in the industry, including up and coming litigation stars Daryl Wiesen and Frederick Rein. Both Wiesen and Rein are extremely active in the industry, working for several Boston-based universities in helping protect their IP rights and assets. David Hashmall, the firm's head of the litigation group, has been practicing for over 30 years and can impart his experience on Goodwin Procter's talented litigation team.
Goodwin's unique business centered philosophy regarding patents has helped the firm become one of the leading IP firms in the life sciences community. Determining and protecting their client's IP value to help meet business objectives is a trait that allows Goodwin Procter's IP group to stand out among those within the industry.
| Practice group breakdown of Life Science Stars |
 |